[High affinity binding of Y-25130 for serotonin 3 receptor]
- PMID: 1330854
- DOI: 10.1254/fpj.100.137
[High affinity binding of Y-25130 for serotonin 3 receptor]
Abstract
The binding of Y-25130 on serotonin 3 (5-HT3) receptors was evaluated by examining its effect on 3H-BRL 43694 (3H-granisetron) binding to rat cerebral cortex membranes in comparison with those of granisetron, ondansetron and metoclopramide. Y-25130, granisetron, ondansetron, metoclopramide, 5-HT and 2-methyl-5-HT displaced the specific binding of 3H-granisetron to the synaptosomal membranes in a concentration-dependent manner. The rank order of potency for inhibition of 3H-granisetron binding by the test compounds was Y-25130 not equal to granisetron greater than ondansetron much greater than 2-methyl-5-HT not equal to 5-HT not equal to metoclopramide. To determine the manner of interaction between Y-25130 and 5-HT3 receptors, Scatchard analysis of 3H-granisetron specific binding to the membranes of the cerebral cortex in the absence or presence of various concentrations of Y-25130 was performed. It was indicated that Y-25130 exerted a typical competitive-type inhibition of 3H-granisetron binding. The present study indicates that Y-25130 binds competitively to 5-HT3 receptors with high affinity.
Similar articles
-
Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.Biochem Pharmacol. 1993 May 25;45(10):2155-8. doi: 10.1016/0006-2952(93)90030-z. Biochem Pharmacol. 1993. PMID: 8390263
-
Antagonistic activity of Y-25130 on 5-HT3 receptors.Jpn J Pharmacol. 1992 Aug;59(4):443-8. doi: 10.1254/jjp.59.443. Jpn J Pharmacol. 1992. PMID: 1331590
-
High affinity binding of azasetron hydrochloride to 5-hydroxytryptamine3 receptors in the small intestine of rats.Jpn J Pharmacol. 1997 Apr;73(4):357-60. doi: 10.1254/jjp.73.357. Jpn J Pharmacol. 1997. PMID: 9165374
-
Development of high-affinity 5-HT3 receptor antagonists. 1. Initial structure-activity relationship of novel benzamides.J Med Chem. 1992 Mar 6;35(5):895-903. doi: 10.1021/jm00083a014. J Med Chem. 1992. PMID: 1312602
-
5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.Drugs. 1998 Feb;55(2):173-89. doi: 10.2165/00003495-199855020-00002. Drugs. 1998. PMID: 9506240 Review.
Cited by
-
A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy.Cancer Res Treat. 2014 Jan;46(1):19-26. doi: 10.4143/crt.2014.46.1.19. Epub 2014 Jan 15. Cancer Res Treat. 2014. PMID: 24520219 Free PMC article.
-
Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin.Eur J Drug Metab Pharmacokinet. 2015 Mar;40(1):39-44. doi: 10.1007/s13318-014-0175-z. Epub 2014 Jan 28. Eur J Drug Metab Pharmacokinet. 2015. PMID: 24470169
-
Comparison of azasetron and ondansetron for preventing postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery.Yonsei Med J. 2010 Jan;51(1):88-92. doi: 10.3349/ymj.2010.51.1.88. Epub 2009 Dec 29. Yonsei Med J. 2010. PMID: 20046519 Free PMC article. Clinical Trial.
-
Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists.Int J Clin Oncol. 2009 Dec;14(6):518-24. doi: 10.1007/s10147-009-0912-5. Epub 2009 Dec 5. Int J Clin Oncol. 2009. PMID: 19967488
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources